CCG-203971
Product Specifications
Target
Rho|||Ras
Related Pathways
Cell Cycle/Checkpoint|||MAPK|||GPCR/G Protein
Purity
0.995
Bioactivity
CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 ?M), with 87% inhibition of SRE activation achieved at 100 ?M. This compound also inhibits PC-3 cell migration (IC50: 4.2 ?M), as determined by a scratch wound assay. CCG-203971 (CCG203971) causes no cytotoxicity when evaluated by the WST-1 assay. It is well tolerated in normal mice up to doses of 100 mg/kg given intraperitoneally over five days.
Smiles
Clc1ccc(NC(=O)C2CCCN(C2)C(=O)c2cccc(c2)-c2ccco2)cc1
Molecular Formula
C23H21ClN2O3
Molecular Weight
408.88
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/322D8ED7-0289-447B-BD96-D47306E137D0/T4306
CAS Number
1443437-74-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
